Negosiasi harga obat Medicare mungkin tidak terlalu berdampak pada produsen obat
Keuangan Negosiasi harga obat Medicare mungkin tidak terlalu berdampak pada produsen obat 6 menit yang lalu Berita Bitcoin Ethereum In this photo illustration, Eliquis is made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. Medicare is set to negotiate prices for 10 different drugs with manufacturers in a bid to make those costly treatments more affordable for older Americans – a process the pharmaceutical industry fiercely opposes. But analysts say the drug price talks will likely have a muted financial impact on manufacturers, at least for this first round of prescription medicines. Thats because other factors are already expected to weigh on the revenue and profits of the drugs on the list, which could minimize any negative impact from lower negotiated prices that are set in place. For example, many of the drugs are already facing strong competition from other branded medications or patent expirations in the coming years that will open the market to generic alternatives. More broadly, some of the drugs on the list aren‘t significant contributors to their company’s business in the first place. “The commercial impact of negotiations appears limited in the near term for this initial list of drugs,” Mara Goldstein, managing director of Mizuho Securities,









